2021 annual financial data
Vivos Therapeutics 2021 Operating margin
Direct answer
Operating margin was -115.32%.
Operating income was -19,471,000 USD and net income was -20,288,000 USD.
Operating cash flow was -15,735,000 USD.
Get free Vivos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,885,000 USD
- Operating income
- -19,471,000 USD
- Net income
- -20,288,000 USD
- Operating cash flow
- -15,735,000 USD